Cancer Screening and Prevention Research Group

The Cancer Screening and Prevention Research Group (CSPRG) is an internationally renowned cancer research group based at Imperial College London. The research focus of the CSPRG is gastrointestinal cancers including bowel cancer, also known as colorectal cancer, oesophageal cancer and gastric cancers. In the UK, over 41,000 people are diagnosed with bowel cancer alone every year and 16,000 people die from the disease. Through our research we hope to reduce the numbers of people receiving a diagnosis of gastrointestinal cancer and dying from this disease. Much of our work focuses on how to help make bowel cancer screening and surveillance programmes more effective and acceptable for participants, and more efficient for the NHS, and other health services internationally. We conduct large-scale studies by either recruiting people from participating healthcare providers or by collating and analysing data collected from UK-based hospitals and other data providers. We receive funding from the UK Government, through the Department of Health and research councils, as well as charities including Cancer Research UK.